Clinical Trial Update: A Study on the Efficacy and Safety of Continuous Renal Replacement Therapy (CVVHDF) Using a Commercial Citrate-containing Replacement Fluid (Prismocitrate 18/0) [NA]

View source ↗

Summary

This completed clinical trial evaluated the efficacy and safety of continuous venovenous hemodiafiltration using a citrate-containing replacement fluid (Prismoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Prismocitrate 18/0 (citrate-containing replacement fluid for CVVHDF)

Snippet

Sponsor: The University of Hong Kong | Conditions: Renal Failure | NA | Status: COMPLETED